Compare GRFS & PSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | PSN |
|---|---|---|
| Founded | 1940 | 1944 |
| Country | Spain | United States |
| Employees | 23800 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 7.7B |
| IPO Year | N/A | 2019 |
| Metric | GRFS | PSN |
|---|---|---|
| Price | $8.93 | $66.19 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 14 |
| Target Price | $10.15 | ★ $84.00 |
| AVG Volume (30 Days) | 446.1K | ★ 1.3M |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | ★ 1.54% | N/A |
| EPS Growth | N/A | ★ 3.77 |
| EPS | N/A | ★ 2.20 |
| Revenue | N/A | ★ $6,364,245,000.00 |
| Revenue This Year | $5.47 | $6.45 |
| Revenue Next Year | $4.92 | $7.69 |
| P/E Ratio | ★ $18.67 | $29.63 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.19 | $54.56 |
| 52 Week High | $11.14 | $89.50 |
| Indicator | GRFS | PSN |
|---|---|---|
| Relative Strength Index (RSI) | 42.21 | 49.38 |
| Support Level | $8.66 | $60.45 |
| Resistance Level | $9.11 | $70.39 |
| Average True Range (ATR) | 0.29 | 2.27 |
| MACD | -0.05 | 0.10 |
| Stochastic Oscillator | 42.28 | 63.27 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.